CCR2: Characterization of the Antagonist Binding Site from a Combined Receptor Modeling/Mutagenesis Approach

Citations Over TimeTop 17% of 2003 papers

Abstract

We describe here a classical molecular modeling exercise that was carried out to provide a basis for the design of novel antagonist ligands of the CCR2 receptor. Using a theoretical model of the CCR2 receptor, docking studies were carried out to define plausible binding modes for the various known antagonist ligands, including our own series of indole piperidine compounds. On the basis of these results, a number of site-directed mutations (SDM) were designed that were intended to verify the proposed docking models. From these it was clear that further refinements would be necessary in the model. This was aided by the publication of a crystal structure of bovine rhodopsin, and a new receptor model was built by homology to this structure. This latest model enabled us to define ligand-docking hypotheses that were in complete agreement with the results of the SDM experiments.

Related Papers

• → Monomeric G-Protein-Coupled Receptor as a Functional Unit(2005)215 cited
• → A concept for G protein activation by G protein-coupled receptor dimers: the transducin/rhodopsin interface(2004)169 cited
• → Relevance of rhodopsin studies for GPCR activation(2013)63 cited
• → The Crystallographic Model of Rhodopsin and Its Use in Studies of Other G Protein–Coupled Receptors(2003)133 cited
• → Expression of functional G protein‐coupled receptors in photoreceptors of transgenic Xenopus laevis(2006)